Article
Tissue-specific transcriptomic changes associated with AmBisome® treatment of BALB/c mice with experimental visceral leishmaniasis
2019-12-10
Abstract excerpt
<h4>Background: </h4> Liposomal amphotericin B (AmBisome®) as a treatment modality for visceral leishmaniasis (VL) has had significant impact on patient care in some but not all regions where VL is endemic. As the mode of action of AmBisome® in vivo is poorly understood, we compared the tissue-specific transcriptome in drug-treated vs untreated mice with experimental VL. <h4>Methods: </h4>: BALB/c mice infe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 829d198e-03df-5806-94c6-2f751f231172
- DOI
- 10.12688/wellcomeopenres.15606.1
